| Allergan, Inc. News (2003-2004) |
 |
| Thursday, November 6, 2008 |
| IRVINE--- Spectrum Pharmaceuticals Announces Receipt of $41.5 Million from Allergan, Inc. Per Collaboration Agreement for Apaziquone Announced on October 29th Posted 3:37 PM PST |
| |
| Wednesday, October 29, 2008 |
| IRVINE--- Allergan, Inc. and Spectrum Pharmaceuticals, Inc. Announce Collaboration Agreement for Apaziquone (EOquin®) Posted 5:22 AM PST |
| |
| Friday, October 24, 2008 |
| COSTA MESA--- Ista Pharmaceuticals Inc. Tops Deloitte's Orange County Technology Fast 50 Ranking of Fastest Growing Companies, With 21075.18 Percent Revenue Growth Over Five Years Posted 5:26 AM PST |
| |
| Thursday, October 23, 2008 |
| GOLETA--- BAROnova Secures Investment From Allergan, Inc. Posted 6:41 AM PST |
| |
| Friday, October 3, 2008 |
| IRVINE--- Allergan Announces Quarterly Conference Call Posted 3:58 PM PST |
| |
| Monday, September 29, 2008 |
| ACADIA Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference on October 6, 2008 Posted 7:44 AM PST |
| |
| Friday, September 12, 2008 |
| SAN FRANCISCO--- US Neuropathic Pain Market Value Doubles to $5 Billion by 2018 Posted 6:30 AM PST |
| |
| Thursday, September 11, 2008 |
| IRVINE--- Allergan Announces Positive Top-Line Results from Phase III BOTOX Headache Program Posted 8:42 AM PST |
| |
| Friday, September 5, 2008 |
| ACADIA Pharmaceuticals Files Registration Statement as Required by Previously Announced Committed Equity Financing Facility Posted 3:18 PM PST |
| |
| Thursday, August 28, 2008 |
| ACADIA Pharmaceuticals to Present at The Thomas Weisel Partners Healthcare Conference on September 4, 2008 Posted 7:42 AM PST |
| |
| Tuesday, August 26, 2008 |
| HUNTINGTON BEACH--- Supplier Market for U.S. Minimally Invasive Aesthetic Products Poised to Grow from $1.5 Billion in 2007 to Nearly $2.5 Billion by 2016 Posted 3:27 PM PST |
| |
| Tuesday, August 5, 2008 |
| SAN DIEGO--- ACADIA Pharmaceuticals Secures Committed Equity Financing Facility Posted 6:54 AM PST |
| |
| Tuesday, June 24, 2008 |
| SCOTTS VALLEY--- Compassoft has a New President and CEO; Paul Salesgiver Brings 30 Years of Experience to the Job Posted 3:00 PM PST |
| |
| Monday, June 9, 2008 |
| IRVINE--- Allergan Announces Agreement to Acquire Aczone Gel 5% Posted 6:35 AM PST |
| |
| Thursday, May 29, 2008 |
| SAN DIEGO--- Douglas Abel Joins Artes Medical’s Board of Directors Posted 5:56 PM PST |
| |
| Wednesday, May 21, 2008 |
| SANTA ANA--- Communicado Offers Quick Start Dealer Program for Converged Communications Solutions Posted 6:29 AM PST |
| |
| Wednesday, May 14, 2008 |
| PETALUMA--- Raydiance Names Mel Engle as Chief Executive Officer; Barry Schuler to Become Executive Chairman Posted 9:14 AM PST |
| |
| Thursday, May 1, 2008 |
| IRVINE--- Allergan Announces Research & Development Technology Review Posted 3:17 PM PST |
| |
| Wednesday, April 30, 2008 |
| SAN MATEO--- BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology Posted 8:18 AM PST |
| |
| Wednesday, March 26, 2008 |
| COSTA MESA--- Communicado Releases Streamline Management as a Service Version 2.3 Posted 5:49 AM PST |
| |
| Friday, March 21, 2008 |
| COSTA MESA--- Communicado Streamline Named Product of the Year by Unified Communications Magazine Posted 6:47 AM PST |
| |
| Wednesday, February 27, 2008 |
| IRVINE--- SoCalBio HR Conference to Examine Greater Los Angeles Region’s Biomed and Biotech Employment Trends, Challenges and Opportunities Posted 3:42 PM PST |
| |
| Wednesday, January 30, 2008 |
| COSTA MESA--- Communicado and Logix Group Sign Pan-European Distribution Agreement to Deliver Converged Communications Management as a Service Posted 7:50 AM PST |
| |
| Tuesday, January 22, 2008 |
| COSTA MESA--- Communicado Appoints Industry Veteran Kelly Anderson to Lead Sales Posted 7:49 AM PST |
| |
| Tuesday, January 15, 2008 |
| COSTA MESA--- Communicado Streamline Named Product of the Year by INTERNET TELEPHONY Magazine Posted 8:46 AM PST |
| |
| Thursday, December 6, 2007 |
| IRVINE--- Allergan Announces New Board Member; Dawn Hudson Appointed Posted 5:22 PM PST |
| |
| Monday, November 12, 2007 |
| IRVINE--- Allergan, Inc. and Covidien Ltd. Enter into Co-Promotion Agreement for LAP-BAND® Adjustable Gastric Banding System Posted 8:01 AM PST |
| |
| Wednesday, October 31, 2007 |
| IRVINE--- Allergan, Inc. Receives FDA Approval for COMBIGAN (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% Posted 5:33 AM PST |
| |
| Wednesday, October 17, 2007 |
| IRVINE--- Allergan Announces Completion of Esprit Pharma Acquisition Posted 3:29 PM PST |
| |
| Wednesday, September 19, 2007 |
| IRVINE--- Allergan, Inc. Announces Agreement to Acquire Esprit Pharma, Inc. Posted 5:51 AM PST |
| |
| Monday, August 20, 2007 |
| COSTA MESA--- Communicado Delivers Converged Communications Management as a Service Posted 6:33 AM PST |
| |
| Monday, August 13, 2007 |
| COSTA MESA--- SyncVoice Communications Raises $11.6 Million in Series B Financing; Changes Name to Communicado Posted 8:39 AM PST |
| |
| Monday, July 16, 2007 |
| ACADIA Pharmaceuticals Earns Milestone on Advancement of Glaucoma Drug Candidate Posted 7:52 AM PST |
| |
| Tuesday, June 26, 2007 |
| IRVINE--- Allergan Announces FDA Approval of Label Extensions for JUVÉDERM Ultra and JUVÉDERM Ultra Plus Posted 11:02 AM PST |
| |
| Wednesday, May 16, 2007 |
| SAN DIEGO--- Halozyme Therapeutics Names Randal J. Kirk and Kathryn E. Falberg to Board of Directors Posted 7:23 AM PST |
| |
| Thursday, May 10, 2007 |
| SAN DIEGO--- La Jolla Pharmaceutical Company Names Niv Caviar Chief Business and Financial Officer Posted 4:22 PM PST |
| |
| Tuesday, May 8, 2007 |
| ACADIA Pharmaceuticals Reports First Quarter 2007 Financial Results Posted 5:07 PM PST |
| |
| Wednesday, May 2, 2007 |
| IRVINE--- Allergan Reports First Quarter Operating Results Posted 7:44 AM PST |
| |
| Wednesday, April 18, 2007 |
| SANTA BARBARA--- Aesthetics and Plastic Surgery Company Sientra Inc. Raises $85 Million in Series B Financing Posted 4:43 PM PST |
| |
| Monday, April 16, 2007 |
| NEWPORT BEACH--- $2 Billion U.S. Market for Aesthetic Devices and Therapies Set to Double in Next Four Years, According to a New Report from Medtech Insight/Windhover Information Posted 3:10 PM PST |
| |
| Wednesday, March 14, 2007 |
| IRVINE--- Broadcom Names Veteran Executive Eric Brandt as Chief Financial Officer Posted 3:32 PM PST |
| |
| Thursday, February 22, 2007 |
| IRVINE--- Allergan Announces Its Acquisition of EndoArt, a Leading Swiss Developer of Remote-Controlled Medical Devices Posted 8:11 AM PST |
| |
| Wednesday, January 17, 2007 |
| IRVINE--- Allergan, Inc. Announces Nationwide Availability of JUVÉDERM ULTRA and JUVÉDERM ULTRA PLUS Dermal Fillers Posted 7:53 AM PST |
| |
| Thursday, December 21, 2006 |
| IRVINE--- Allergan Announces FDA Issues Approvable Letter for COMBIGAN (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% Posted 5:27 PM PST |
| |
| Wednesday, December 6, 2006 |
| IRVINE--- Allergan’s Jeffrey L. Edwards Named Orange County CFO of the Year by NIRI Orange County and UCI Extension Posted 7:43 AM PST |
| |
| Monday, December 4, 2006 |
| IRVINE--- Allergan Announces New Board Member; Dr. Deborah Dunsire Appointed Posted 4:02 PM PST |
| |
| Friday, November 17, 2006 |
| FDA Approves Allergan's Silicone-Filled Breast Implants for Breast Augmentation, Reconstruction and Revision Surgery Posted 3:14 PM PST |
| |
| Tuesday, November 14, 2006 |
| IRVINE--- Triage Medical Names Walter A. Cuevas as Its Chief Executive Officer Posted 5:55 AM PST |
| |
| Monday, November 6, 2006 |
| ACADIA Pharmaceuticals Reports Third Quarter 2006 Financial Results Posted 2:30 PM PST |
| |
| Wednesday, November 1, 2006 |
| IRVINE--- Allergan Reports Third Quarter Operating Results Posted 7:40 AM PST |
| |
| Monday, October 30, 2006 |
| SAN FRANCISCO--- Merck & Co., Inc. to Acquire Sirna Therapeutics, Inc. Posted 3:39 PM PST |
| |
| Thursday, October 5, 2006 |
| IRVINE--- Allergan Integrates Inamed’s Commercial and Research and Development Operations within New Corporate Division, Allergan Medical Posted 7:19 AM PST |
| |
| Tuesday, September 26, 2006 |
| IRVINE--- Allergan, Inc. Announces Launch of JUVEDERM ULTRA and JUVEDERM ULTRA PLUS Posted 5:20 AM PST |
| |
| Monday, August 14, 2006 |
| COSTA MESA--- Valeant Pharmaceuticals Mourns Death of Chairman Robert W. O'Leary; Board of Directors Elects Robert A. Ingram as Chairman of the Board Posted 4:02 PM PST |
| |
| Tuesday, August 8, 2006 |
| ACADIA Pharmaceuticals Reports Second Quarter 2006 Financial Results Posted 3:29 PM PST |
| |
| Tuesday, July 25, 2006 |
| IRVINE--- IntraLase Names New Board Member; Michael Ball, President of Allergan, Inc., Joins IntraLase Board Posted 2:46 PM PST |
| |
| Friday, June 23, 2006 |
| IRVINE--- Allergan Announces FDA Approval of LUMIGAN(R) as First-Line Treatment for Elevated Eye Pressure in Open-Angle Glaucoma; Indication Expands Approved Uses of LUMIGAN(R) in the Management of Glaucoma Posted 6:29 AM PST |
| |
| Tuesday, June 13, 2006 |
| SAN DIEGO--- Galapagos to Acquire Drug Discovery Service Operations of Discovery Partners International; Acquisition Positions BioFocus as Top Five Player Worldwide in Drug Discovery Services Posted 7:14 AM PST |
| |
| Thursday, May 25, 2006 |
| IRVINE--- Allergan Receives Pan European License for GANFORT(R) (LUMIGAN(R)/Timolol Combination) from European Commission Posted 5:43 AM PST |
| |
| Monday, May 22, 2006 |
| SAN MATEO--- SuccessFactors Raises $45 Million to Continue Fueling Customer-Focused, Triple-Digit Growth Posted 4:15 PM PST |
| |
| Wednesday, May 10, 2006 |
| ACADIA Pharmaceuticals Reports First Quarter 2006 Financial Results Posted 2:38 PM PST |
| |
| Wednesday, April 19, 2006 |
| IRVINE--- Allergan Announces Quarterly Conference Call Posted 4:10 PM PST |
| |
| Thursday, April 13, 2006 |
| IRVINE--- Allergan's Chairman and Chief Executive Officer Adopts Rule 10b5-1 Stock Trading Plan Posted 7:19 AM PST |
| |
| Tuesday, April 11, 2006 |
| SAN FRANCISCO--- CoTherix Appoints Abhay Joshi as EVP and Chief Technical Officer Posted 7:16 AM PST |
| |
| Friday, April 7, 2006 |
| IRVINE--- Allergan Announces Exercise of Over-Allotment Options for $50 Million of 1.50% Convertible Senior Notes Posted 4:22 PM PST |
| |
| Thursday, March 30, 2006 |
| FOUNTAIN VALLEY--- D-Link's Steven Joe Awarded 'Advocate of the Year' From University of California Alumni Association Posted 4:30 PM PST |
| |
| Monday, March 27, 2006 |
| IRVINE--- Allergan Announces 2006 Financial Guidance and Investor Call Posted 8:42 AM PST |
| |
| Friday, March 24, 2006 |
| IRVINE--- Allergan Receives Positive Opinion for GANFORT(R) (LUMIGAN(R)/Timolol Combination) in European Union Posted 7:34 AM PST |
| |
| Thursday, March 23, 2006 |
| IRVINE--- Allergan Announces Completion of Inamed Acquisition Posted 6:54 AM PST |
| |
| Monday, March 20, 2006 |
| IRVINE--- Allergan Completes Exchange Offer for Inamed Corporation; Anticipates Prompt Completion of Acquisition Posted 7:05 AM PST |
| |
| Tuesday, March 14, 2006 |
| SAN FRANCISCO--- Sirna Therapeutics Announces Its Scientific Advisory Board Posted 8:23 AM PST |
| |
| Monday, March 13, 2006 |
| IRVINE--- Allergan Announces Final Extension of Inamed Exchange Offer and Amendment to Merger Agreement Posted 7:57 AM PST |
| |
| Thursday, March 9, 2006 |
| IRVINE--- Allergan and Alcon Reach Agreement on Brimonidine 0.15% Patent Litigation Posted 8:24 AM PST |
| |
| Wednesday, March 8, 2006 |
| IRVINE--- Allergan Receives Final U.S. Antitrust Approval of Inamed Acquisition Posted 4:33 PM PST |
| |
| Monday, March 6, 2006 |
| IRVINE--- Allergan Announces Signing of FTC Consent Order Posted 10:30 AM PST |
| |
| Friday, March 3, 2006 |
| IRVINE--- Allergan Announces Increase in Q4 and Full Year 2005 Earnings Per Share Following Agreement with U.S. Internal Revenue Service Posted 5:06 PM PST |
| |
| Wednesday, March 1, 2006 |
| SAN DIEGO--- AVANIR Pharmaceuticals Hires Matthew R. Ruth as Vice President of Sales Posted 5:14 PM PST |
| |
| Thursday, February 23, 2006 |
| IRVINE--- ISTA Pharmaceuticals, Inc. Reports Fourth Quarter and Year End 2005 Financial Results Posted 8:12 AM PST |
| |
| Tuesday, February 21, 2006 |
| IRVINE--- Allergan Extends Expiration Date of Inamed Exchange Offer Posted 4:05 PM PST |
| |
| Thursday, February 16, 2006 |
| SUNNYVALE--- Kyphon Announces Promotion of Arthur T. Taylor to Chief Operating Officer Posted 4:27 PM PST |
| |
| Wednesday, February 15, 2006 |
| PALO ALTO--- Netli Secures $18 Million in Oversubscribed Expansion Round From Leading Investors; Investment Will Fuel Growth to Address the Rapidly Expanding Application and Content Delivery Market Posted 8:37 AM PST |
| |
| Monday, February 6, 2006 |
| IRVINE--- Allergan Extends Expiration Date of Inamed Exchange Offe Posted 8:10 AM PST |
| |
| Thursday, February 2, 2006 |
| IRVINE--- Allergan Reports Fourth Quarter Operating Result Posted 7:57 AM PST |
| |
| Tuesday, January 24, 2006 |
| IRVINE--- Allergan Announces Quarterly Conference Call Posted 3:18 PM PST |
| |
| Tuesday, December 6, 2005 |
| IRVINE--- Allergan Completes Negotiation of Terms and Conditions of Merger Agreement with Inamed Posted 9:01 AM PST |
| |
| Monday, November 21, 2005 |
| IRVINE--- Allergan, Inc. Commences Exchange Offer for Shares of Inamed Corporation Posted 9:28 AM PST |
| |
| Thursday, November 17, 2005 |
| SCOTTS VALLEY--- Compassoft Acquires Wimmer Systems to Bolster Spreadsheet Controls Posted 8:35 AM PST |
| |
| Wednesday, November 16, 2005 |
| IRVINE--- Allergan Comments on Inamed Statement Posted 6:07 PM PST |
| |
| Tuesday, November 15, 2005 |
| IRVINE--- Allergan, Inc. Proposes to Acquire Inamed Corporation for $84 Per Share; Acquisition to Create a World Leading Franchise in High-Growth Medical Aesthetics; Expands Allergan's Position as Premier Specialty Pharmaceutical Company Posted 10:14 AM PST |
| |
| Monday, November 14, 2005 |
| SAN DIEGO--- AVANIR Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors Posted 8:25 AM PST |
| |
| Thursday, November 10, 2005 |
| Acadia Pharmaceuticals Reports Third Quarter 2005 Financial Results Posted 5:04 PM PST |
| |
| Tuesday, November 8, 2005 |
| IRVINE--- ISTA Pharmaceuticals Reports Third Quarter 2005 Financial Results Posted 9:22 AM PST |
| |
| Tuesday, November 1, 2005 |
| IRVINE--- Allergan Reports Third Quarter Operating Results and Increases Full Year Earnings Guidance Posted 9:48 AM PST |
| |
| Discovery Partners International Reports Third Quarter 2005 Results Posted 8:43 AM PST |
| |
| Monday, October 3, 2005 |
| IRVINE--- Allergan Enters Into Agreement with GlaxoSmithKline to Accelerate BOTOX(R) Development and Commercialization in Japan and China, Co-Promote IMITREX STATdose System(R) and AMERGE(R) in U.S. Posted 9:36 AM PST |
| |
| ACADIA Pharmaceuticals Earns Milestone on Advancement of Neuropathic Pain Clinical Program Posted 9:05 AM PST |
| |
| Wednesday, September 28, 2005 |
| IRVINE--- Allergan Receives Positive Opinions for COMBIGAN(TM) from 21 Countries in European Union Posted 10:15 AM PST |
| |
| Tuesday, August 23, 2005 |
| IRVINE--- Jeffrey Edwards Promoted to Executive Vice President, Finance and Business Development, Chief Financial Officer as Eric Brandt Resigns to Accept Position as President and Chief Executive Officer of Avanir Pharmaceuticals Posted 7:39 PM PST |
| |
| SAN DIEGO--- Eric Brandt to Be President and Chief Executive Officer of AVANIR Pharmaceuticals Posted 6:11 PM PST |
| |
| Friday, August 19, 2005 |
| IRVINE--- New Formulation of Allergan's ALPHAGAN(R) P Receives U.S. FDA Approval Posted 6:09 PM PST |
| |
| Monday, August 15, 2005 |
| FOSTER CITY--- Former Genentech CFO to Join Equinix Board of Directors Posted 10:00 AM PST |
| |
| Wednesday, August 10, 2005 |
| ACADIA Pharmaceuticals Reports Second Quarter 2005 Financial Results Posted 4:44 PM PST |
| |
| Thursday, April 7, 2005 |
| IRVINE--- Study Published in Journal Headache Shows Botox-R- May Reduce the Frequency of Headaches in Patients with a Chronic Form of Migraine Posted 8:28 AM PST |
| |
| Thursday, March 3, 2005 |
| ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2004 Posted 5:43 PM PST |
| |
| Wednesday, March 2, 2005 |
| IRVINE--- ISTA Pharmaceuticals Reports Fourth Quarter and Year End 2004 Financial Results Posted 10:45 AM PST |
| |
| Friday, February 25, 2005 |
| IRVINE--- Spectrum Pharmaceuticals Strengthens Management Team and Adds Industry Expertise and Capabilities With Key Promotions and Appointments Posted 9:18 AM PST |
| |
| Wednesday, February 9, 2005 |
| Allergan Comments on Diquafosol Results Posted 11:11 AM PST |
| |
| Tuesday, February 1, 2005 |
| SAN DIEGO--- AVANIR Invites Shareholders to Its Annual Meeting and Profiles New Director Nominees Posted 11:42 AM PST |
| |
| Friday, January 28, 2005 |
| FOOTHILL RANCH--- Cardiogenesis Names Charles J. Scarano Vice President, General Manager of International Business Division Posted 11:52 AM PST |
| |
| Tuesday, January 25, 2005 |
| SAN DIEGO--- ResMed Appoints Two Independent Directors; Board of Directors Expanded to Eight Members Posted 10:30 PM PST |
| |
| Wednesday, August 11, 2004 |
| ACADIA Pharmaceuticals Reports Second Quarter 2004 Financial Results Posted 4:46 PM PST |
| |
| Tuesday, February 10, 2004 |
| Discovery Partners International Reports Fourth Quarter and Year 2003 Results With Record Net Income and Profit From Operations Posted 8:14 AM PST |
| |
| Thursday, January 8, 2004 |
| ACADIA Pharmaceuticals Achieves Milestone as Allergan Advances Glaucoma Drug Candidate Posted 9:14 AM PST |
| |
| Thursday, December 4, 2003 |
| Discovery Partners International, Inc. and Allergan Enter Into Lead Finding Collaboration Posted 9:07 AM PST |
| |
| Monday, May 5, 2003 |
| LA JOLLA--- ActivX Biosciences Appoints J.C. MacRae Executive Vice President and Chief Financial Officer Posted 7:49 AM PST |
| |
| Tuesday, April 15, 2003 |
| Allergan and ACADIA Pharmaceuticals Announce New Drug Discovery and Development Collaboration Posted 7:02 AM PST |
| |
| Wednesday, March 26, 2003 |
| SAN DIEGO--- Sanderling Ventures Appoints Paul A. Grayson As a Director of Its San Diego Office Posted 7:49 AM PST |
| |
| Thursday, January 9, 2003 |
| CARLSBAD--- The Immune Response Corporation Appoints John N. Bonfiglio, Ph.D. Chief Executive Officer; New CEO Brings Biotechnology Turnaround and Drug Development Experience Posted 8:00 AM PST |
| |
